Previous Page  4 / 34 Next Page
Information
Show Menu
Previous Page 4 / 34 Next Page
Page Background

Page 29

Notes:

conferenceseries

.com

October 20-22, 2016 Rome, Italy

11

th

International Conference and Expo on

Nanoscience and Molecular Nanotechnology

Volume 7, Issue 5 (Suppl)

J Nanomed Nanotechnol 2016

ISSN: 2157-7439 JNMNT an open access journal

NanoScience 2016

October 20-22, 2016

Natural products loaded in nanocarriers: An opportunity to increase stability, oral bioavailability and

bioefficacy

Anna Rita Bilia

University of Florence, Italy

N

atural products represent a main source of drugs due to their enormous structural and chemical diversity. They may have

additive/synergistic or antagonistic effects, or possess unique mechanisms of action (i.e. taxol activity on tubulin polymerization),

others can modulate multiple targets or activating multiple pathwaysdriving fundamental biological processes. A paradigmatic

example is curcumin, it is a highly pleiotropic molecule with anti-inflammatory, anti-oxidant, chemopreventive, chemosensitization,

and radiosensitization activities. In spite of these advantages, several questions concerning the role of natural compounds in the

treatment of some diseases remain unanswered, principally due to the transferability of

in vitro

to

in vivo

and ultimately to human

studies: mostly of promising molecules in cell-based assays fail in phase II and phase III. This passage from impressive

in vitro

activity to less or no significant

in vivo

efficacy is generally due to their poor water solubility, high lipophilicity resulting in poor

absorption and hence poor systemic bioavailability, resulting in less or no therapeutic effects. Another problem is their instability

in biological milieu, premature drug loss through rapid clearance and biotransformation. Over the last ten years, our laboratory has

formulated biocompatible and biodegradablenanocarriers encapsulating various imperative natural products including artemisinin

and derivatives, curcumin, andrographolide, salvianolic acid, verbascoside, flavonoids. The developed new dosage forms, namely

micelles, vesicles, nanoparticles, microemulsions, solid lipid nanoparticles and structured lipid capsules performed several sound

characteristics and functions, which are currently unavailable in conventional formulations of natural drugs, such as enhanced

solubility and stability, effect of targeting and increasing bioavailability.

Acknowledgments: this work was supported by Ente Cassa di Risparmio di Firenze.

Biography

Anna Rita Bilia is Associate Professor at the Department of Chemistry of the University of Florence, and Director of the Post-graduate School of Hospital Pharmacy.

She is President of the International Society for Medicinal Plant and Natural Product Research and President of the Italian Society of Phytochemistry. She is Italian

delegate at the European Scientific Cooperative for Phytotherapy and Expert of the European Pharmacopoeia. She published more than 180 scientific papers,

several books chapters and invited reviews in reputed journals. She is Editor and Editorial Board Member of several international scientific journals.

ar.bilia@unifi.it

Anna Rita Bilia, J Nanomed Nanotechnol 2016, 7:5 (Suppl)

http://dx.doi.org/10.4172/2157-7439.C1.043